Medicare paid hospitals substantially more—almost $4 billion in aggregate—than the 340B ceiling price costs for dozens of single-source drugs, biologics [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
Prescribers who work in federally qualified health centers (FQHCs) believe the 340B program helps their organizations and patients—even if they [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) on Monday announced Chantelle Britton as its next Office of Pharmacy Affairs (OPA) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmacy benefit managers (PBMs) and insurers operating in Oregon are barred from restricting 340B drug dispensing or limiting the number [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Teva this week added a blood therapy medication to its hospital contract pharmacy restrictions implemented last summer. The [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...] …
